The i3+3 design is accepted and presented at a poster at 2019 ASCO Annual Meeting

Laiya founder Yuan Ji, Professor of Biostatistics at The University of Chicago, presented a poster entitled “The i3+3 Design for Phase I Clinical Trials” at 2019 ASCO Annual Meeting in Chicago, USA. The i3+3 design is the first rule-based dose-finding design with a performance in par with model-based designs like mTPI and mTPI-2. The paper[…]